Gylden Pharma Ltd
4 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A Phase I Study of PepGNP-ChikV in Healthy Volunteers (NCT07394426) | Gylden Pharma Ltd | 2026-08-03 |
| Next Generation T-cell Vaccine Against Coronavirus Disease (COVID-19) (NCT05633446) | Gylden Pharma Ltd | 2025-09-01 |
| A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against SARS-CoV-2 (NCT05113862) | Gylden Pharma Ltd | 2022-01-10 |
| A Phase-I Study of a Nanoparticle-based Peptide Vaccine Against Dengue Virus (NCT04935801) | Gylden Pharma Ltd | 2021-08-02 |
Track Gylden Pharma Ltd automatically
Every clearance here is in the API, with alerts when new ones post.